These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 25092323)

  • 21. Regulatory T cells suppress development of colitis, blocking differentiation of T-helper 17 into alternative T-helper 1 cells.
    Sujino T; Kanai T; Ono Y; Mikami Y; Hayashi A; Doi T; Matsuoka K; Hisamatsu T; Takaishi H; Ogata H; Yoshimura A; Littman DR; Hibi T
    Gastroenterology; 2011 Sep; 141(3):1014-23. PubMed ID: 21699791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SRC1 promotes Th17 differentiation by overriding Foxp3 suppression to stimulate RORγt activity in a PKC-θ-dependent manner.
    Sen S; Wang F; Zhang J; He Z; Ma J; Gwack Y; Xu J; Sun Z
    Proc Natl Acad Sci U S A; 2018 Jan; 115(3):E458-E467. PubMed ID: 29282318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AT-rich-interactive domain-containing protein 5A functions as a negative regulator of retinoic acid receptor-related orphan nuclear receptor γt-induced Th17 cell differentiation.
    Saito Y; Kagami S; Sanayama Y; Ikeda K; Suto A; Kashiwakuma D; Furuta S; Iwamoto I; Nonaka K; Ohara O; Nakajima H
    Arthritis Rheumatol; 2014 May; 66(5):1185-94. PubMed ID: 24782182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-6-mediated Th17 differentiation through RORγt is essential for the initiation of experimental autoimmune myocarditis.
    Yamashita T; Iwakura T; Matsui K; Kawaguchi H; Obana M; Hayama A; Maeda M; Izumi Y; Komuro I; Ohsugi Y; Fujimoto M; Naka T; Kishimoto T; Nakayama H; Fujio Y
    Cardiovasc Res; 2011 Sep; 91(4):640-8. PubMed ID: 21622681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity.
    Huh JR; Leung MW; Huang P; Ryan DA; Krout MR; Malapaka RR; Chow J; Manel N; Ciofani M; Kim SV; Cuesta A; Santori FR; Lafaille JJ; Xu HE; Gin DY; Rastinejad F; Littman DR
    Nature; 2011 Apr; 472(7344):486-90. PubMed ID: 21441909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Small molecule inhibitors of RORγt: targeting Th17 cells and other applications.
    Huh JR; Littman DR
    Eur J Immunol; 2012 Sep; 42(9):2232-7. PubMed ID: 22949321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RORγt and RORα signature genes in human Th17 cells.
    Castro G; Liu X; Ngo K; De Leon-Tabaldo A; Zhao S; Luna-Roman R; Yu J; Cao T; Kuhn R; Wilkinson P; Herman K; Nelen MI; Blevitt J; Xue X; Fourie A; Fung-Leung WP
    PLoS One; 2017; 12(8):e0181868. PubMed ID: 28763457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of N-(4-aryl-5-aryloxy-thiazol-2-yl)-amides as potent RORγt inverse agonists.
    Wang Y; Yang T; Liu Q; Ma Y; Yang L; Zhou L; Xiang Z; Cheng Z; Lu S; Orband-Miller LA; Zhang W; Wu Q; Zhang K; Li Y; Xiang JN; Elliott JD; Leung S; Ren F; Lin X
    Bioorg Med Chem; 2015 Sep; 23(17):5293-302. PubMed ID: 26277758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of RORγt activity and Th17 differentiation by a set of novel compounds.
    Ding Q; Zhao M; Bai C; Yu B; Huang Z
    BMC Immunol; 2015 May; 16():32. PubMed ID: 26021566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of an allosteric binding site for RORγt inhibition.
    Scheepstra M; Leysen S; van Almen GC; Miller JR; Piesvaux J; Kutilek V; van Eenennaam H; Zhang H; Barr K; Nagpal S; Soisson SM; Kornienko M; Wiley K; Elsen N; Sharma S; Correll CC; Trotter BW; van der Stelt M; Oubrie A; Ottmann C; Parthasarathy G; Brunsveld L
    Nat Commun; 2015 Dec; 6():8833. PubMed ID: 26640126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Generation of engineering Th17 cells and its function evaluation].
    Zhang HX; Chen C; Zeng LY; Zhang Y; Xu KL
    Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):825-9. PubMed ID: 22339955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel series of cysteine-dependent, allosteric inverse agonists of the nuclear receptor RORγt.
    Jiang X; Dulubova I; Reisman SA; Hotema M; Lee CI; Liu L; McCauley L; Trevino I; Ferguson DA; Eken Y; Wilson AK; Wigley WC; Visnick M
    Bioorg Med Chem Lett; 2020 Mar; 30(6):126967. PubMed ID: 32005415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological Evaluation of TAK-828F, a Novel Orally Available RORγt Inverse Agonist, on Murine Colitis Model.
    Igaki K; Nakamura Y; Komoike Y; Uga K; Shibata A; Ishimura Y; Yamasaki M; Tsukimi Y; Tsuchimori N
    Inflammation; 2019 Feb; 42(1):91-102. PubMed ID: 30121880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of Pathogenic T Helper 17 Cell Differentiation by Steroid Receptor Coactivator-3.
    Tanaka K; Martinez GJ; Yan X; Long W; Ichiyama K; Chi X; Kim BS; Reynolds JM; Chung Y; Tanaka S; Liao L; Nakanishi Y; Yoshimura A; Zheng P; Wang X; Tian Q; Xu J; O'Malley BW; Dong C
    Cell Rep; 2018 May; 23(8):2318-2329. PubMed ID: 29791844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcription of RORγt in developing Th17 cells is regulated by E-proteins.
    Zhang F; Fuss IJ; Yang Z; Strober W
    Mucosal Immunol; 2014 May; 7(3):521-32. PubMed ID: 24064669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isoflavones enhance interleukin-17 gene expression via retinoic acid receptor-related orphan receptors α and γ.
    Kojima H; Takeda Y; Muromoto R; Takahashi M; Hirao T; Takeuchi S; Jetten AM; Matsuda T
    Toxicology; 2015 Mar; 329():32-9. PubMed ID: 25583575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Dichotomous Nature of AZ5104 (an EGFR Inhibitor) Towards RORγ and RORγT.
    Karaś K; Sałkowska A; Karwaciak I; Walczak-Drzewiecka A; Dastych J; Bachorz RA; Ratajewski M
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31744223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PPARα suppresses Th17 cell differentiation through IL-6/STAT3/RORγt pathway in experimental autoimmune myocarditis.
    Chang H; Zhao F; Xie X; Liao Y; Song Y; Liu C; Wu Y; Wang Y; Liu D; Wang Y; Zou J; Qi Z
    Exp Cell Res; 2019 Feb; 375(1):22-30. PubMed ID: 30557558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benzoxazepines Achieve Potent Suppression of IL-17 Release in Human T-Helper 17 (TH 17) Cells through an Induced-Fit Binding Mode to the Nuclear Receptor RORγ.
    Olsson RI; Xue Y; von Berg S; Aagaard A; McPheat J; Hansson EL; Bernström J; Hansson P; Jirholt J; Grindebacke H; Leffler A; Chen R; Xiong Y; Ge H; Hansson TG; Narjes F
    ChemMedChem; 2016 Jan; 11(2):207-16. PubMed ID: 26553345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of TH17 differentiation and autoimmunity by a synthetic ROR ligand.
    Solt LA; Kumar N; Nuhant P; Wang Y; Lauer JL; Liu J; Istrate MA; Kamenecka TM; Roush WR; Vidović D; Schürer SC; Xu J; Wagoner G; Drew PD; Griffin PR; Burris TP
    Nature; 2011 Apr; 472(7344):491-4. PubMed ID: 21499262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.